Gastric Cancer · 2013 · 67 citations · 38 references
MedicineOncologySurgeryGastroenterologyGastrointestinal OncologySurgical OncologyEndoscopic Tumor ResectionEsophageal SurgeryGastrointestinal Bleeding ManagementGastrointestinal Cancer SurgeryGastrointestinal EndoscopyTherapeutic EndoscopyGastric Cancer PharmacotherapyGastrointestinal Oncologic SurgeryOncologic Gastrointestinal Surgery
BACKGROUND: Although recent guidelines for endoscopic submucosal dissection (ESD) as treatment for early gastric cancer (EGC) recommend noninterruption of low-dose aspirin (LDA) perioperatively, this strategy is controversial. It was our practice to interrupt LDA therapy 5-7 days before to ESD until December 2010, when we instituted the new guidelines and performed ESD without interrupting LDA therapy. Our purpose in this study was to confirm the validity of noninterrupted use of LDA in patients undergoing ESD for EGC. METHODS: We studied 78 consecutive patients with 94 EGCs who were routinely taking LDA and were treated by ESD at Hiroshima University Hospital between April 2005 and June 2012. The patients were of two groups: those in whom LDA was interrupted perioperatively (53 patients with 66 EGCs) and those in whom LDA was continued perioperatively (25 patients with 28 EGCs). RESULTS: The complete resection rate was 92.4 % (61/66) in the LDA-interrupted group and 100 % (28/28) in the LDA-continued group. Incidences of poor bleeding control during the procedure and bleeding after procedure were 10.6 % (7/66) and 4.8 % (3/66), respectively, in the LDA-interrupted group and 7.1 % (2/28) and 3.6 % (1/28) in the LDA-continued group. Two patients in the interrupted-LDA group suffered cerebrovascular infarction before ESD, and 2 patients in this group suffered acute myocardial infarction after ESD. CONCLUSIONS: Our data suggest that continued use of LDA does not increase the risk of bleeding during or after ESD for EGC and does decrease the risk of ischemic events.
38
Japanese classification of gastric carcinoma: 3rd English edition
Gastric Cancer · 2011 · 3.5K citations · Full text
Japanese gastric cancer treatment guidelines 2010 (ver. 3)
Gastric Cancer · 2011 · 2.2K citations · Full text
Endoscopic mucosal resection for treatment of early gastric cancer
Hiroyuki Ono · Gut · 2001 · 1.5K citations · Full text
Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer
Shiro Oka, Shinji Tanaka, Iwao Kaneko et al. · Gastrointestinal Endoscopy · 2006 · 674 citations
Management of antithrombotic agents for endoscopic procedures
Michelle A. Anderson, Tamir Ben‐Menachem, S. Ian Gan et al. · Gastrointestinal Endoscopy · 2009 · 518 citations